English
+38 044 223 28 95
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Request Info

Our stories

Below you can find video testimonials and letters from our patients, their relatives and doctors regarding the effects of stem cell treatment at Cell Therapy Center EmCell. We intentionally do not provide patients' names, as in Ukraine such information is considered medical secrecy.

Professional Opinion


Patient stories

ALS/MND

Patient F.T.G., 47. Amyotrophic lateral sclerosis, cervical form, marked flaccid tetraparesis

Patient B.I., 44. ALS, with cervicothoracic involvement, marked tetraparesis, and bulbar palsy. S.p. disc surgery in 2002

Patient S.M., 68. Amyotrophic lateral sclerosis. Bulbar palsy. Spastic tetraparesis

Patient M.A., 76. Motor neuron disease

Alzheimer’s disease

Patient A.F., 64. Alzheimer’s disease. Nodular polyosteoarthrosis of shoulder joints, small wrist joints

Anti-Aging Treatment

Patient M.N., 42. Anti-aging treatment

Patient G.R.C., 67. Anti-aging treatment

Patient K., 52. Menopause

Patient H., 35. Anti-aging treatment

Patient E.M., 49. Dyshormonal neurocirculatory asthenia

Patient M.H., 50. Chronic fatigue syndrome. Remission of lumbar osteochondrosis with moderate muscle tone abnormalities






Autism

Under 7

Patient A.Z., 3. Autism

Patient H.M., 4. Dyspraxia. Autism

Patient V.S., 6. Autism

Patient K.S., 6. Autism

Patient R.E.A., 6. Autism

7-10 years

Patient D.P., 7. Autism

Patient B.T., 7. Autism

Patient P.M., 7. Autism

Patient C.J.M., 7. Autism

Patient K.C., 8. Autism

Patient J.N., 8. Autism

Patient N.S. 8. Autism

Patient S.S., 8. Autism spectrum disorder

Patient L.C., 8. Autism

Patient O.M.C., 8. Autism

Patient A.L., 10. Autism. Joint hyperlaxity

Patients K.T. and J.P.T., 9 and 10. Autism

Patient M.K. 10. Autism

Patient N.G.G., 10. Autism

11-14 years

Patient R.L. 12. Autism

Patient Ch.M.G. 13. Post-hypoxic encephalopathy with speech disturbances. Autism.

Patient J.G., 14. Autism

Patient G.O., 14. Autism

Over 14

Patient D.L.S., 17. Autism.

Patient R.M., 21. Autism. Toxic hepatitis

Patient D.S., 29. Autism





Cancer

Patient U.M., 57 C-r glandullae bilateralis; condition after combined therapy; prolongatio morbi

Cerebral palsy

Patient K.J., 3. Post-hypoxic encephalopathy. Cerebral palsy with moderate spastic tetraparesis and cognitive problems

Patient M.W., 6. Cerebral palsy with lower paraparesis. Mental and physical delay

Patient C.W., 6. Cerebral palsy

Patient I.C., 2. Сerebral palsy with moderate left-sided hemiparesis

Developmental delay 

Patient L.P., 13. Psychomotor delay and secondary immune deficiency

Patient O.H., 13. Developmental delay.  Well-managed secondary hypothyroid

Patient A.J., 6. Sequels of hypoxic-ischemic damage of the central nervous system with psychomotor delay. Alalia. Symptomatic epilepsy with myoclonic seizures

Patient Z.M., 2. Organic CMV-induced CNS damage with microcephaly, tetraparesis and cognitive deficit

Diabetes

Patient M.A., 49.  Advanced subcompensated diabetes mellitus, type 2

Patient Z., 57. Type 2 moderate subcompensated diabetes mellitus

Patient A., 54. Advanced decompensated type 2 diabetes mellitus. Ischemic heart disease

Patient J. Sch.-J., 49. Type I diabetes and diabetic neuropathy

Patient A.A., 47. Chronic relapsing advanced non-specific ulcerative colitis affecting rectosigmoid, grade II activity. Moderate, poorly managed type 2 diabetes mellitus
 

Eye diseases

Patient I.B., 25. Best's disease (macular dystrophy)

Heart diseases

Patient K.F., 65. IHD: diffuse cardiosclerosis. Atherosclerosis of aorta and coronary arteries with stenosis. Grade I heart failure with preserved LV systolic function, NYHA Class I

Patient A.M., 49. Dilated cardiomyopathy

Patient H.B., 56. IHD: Stable effort angina, NYHA II. Diffuse and postinfarction cardiosclerosis. Atherosclerosis of aorta and coronary arteries with stenosis. S.p. transluminal angioplasty with 4 stents placement.   Subtotal stenosis of the posterior descending artery (branch of the right coronary artery). Essential  hypertension. Moderate decompensated type 2 diabetes mellitus. Hyperuricemia.

Joint diseases

Patient R.N., 43. Non-nodular polyosteoarthrosis of the large joints (knee, hips) without functional insufficiency of the joints

Patient V.K.S., 54. Non-nodular osteoarthritis of the large joints without functional insufficiency of the joints. Unstable remission of extensive osteochondrosis, vertebrogenic brachialgia, lumboischialgia on the right, and pain. Insomnia. Obstructive sleep apnea

Patient D.P., 56. Osteoarthrosis affecting mainly large joints. Varicose veins of lower extremities

Patient  B. G. M., 67. Unstable remission of extensive cervical osteochondrosis with muscle tone abnormalities and moderate pain. Osteoarthrosis of the large joints with grade II-I functional insufficiency of the joints    

Patient N.P., 53. Non-nodular osteoarthrosis, bilateral gonarthrosis without functional insufficiency of the joints. Atopic dermatitis

Patient C.D., 63. Vertebrogenic brachialgia with muscle tone abnormalities and moderate pain. Nodular osteoarthritis of the small and large joints (Heberden’s nodes) without functional insufficiency of the joints. Dyslipidemia

Patient C.D., 31. Secondary osteoarthritis of the left ankle joint (septic arthritis in 2002 with revision surgery in 2002) with grade I functional insufficiency of the joint.  Oligozoospermia (according to the patient)

Patient A.S., 13. Juvenile idiopathic seronegative grade I polyarthritis with contractures of the left elbow joint and IV-V right proximal interphalangeal wrist joints

Muscular Dystrophy

Patient R., 8. Duchenne Muscular Dystrophy

Patient M., 30. Muscular Dystrophy

Patient R. M., 31. Duchenne’s Muscular Dystrophy 

Patient C.M., 10. Muscle dystrophy, stage II

Multiple Sclerosis

Patient H., 42. Multiple sclerosis

Patient V.A., 28. Multiple sclerosis

Patient H.R., 43. Multiple sclerosis; emphysema; pulmonary insufficiency

Patient L.N., 52. Multiple sclerosis

Patient D.M., 29. Remitting-relapsing multiple sclerosis



Patient R.W., 44. Primary progressive cerebrospinal multiple sclerosis with spastic paraparesis of the lower extremities

Patient M.C., 63. Secondary progressive multiple sclerosis with cerebrospinal involvement, spastic paraparesis of lower extremities and urine retention

Patient A.Z.D., 35. Secondary progressive multiple sclerosis with cerebrospinal involvement and spastic paraparesis of the lower extremities and urine retention

Patient B. B., 36. Secondary progressive multiple sclerosis with cerebrospinal involvement and spastic paraparesis of the lower extremities.  EDSS – 5,0.  Urine incontinence. Moderate type 1 diabetes mellitus

Patient B., 47. Primary progressive (most likely) multiple sclerosis with cerebral involvement and moderate paraparesis of the lower extremities.

Patient R.A., 38. Primary progressive multiple sclerosis with cerebrospinal involvement, spastic paraparesis of lower extremities, urine incontinence. Bedsore on the sacrum.

Parkinson's disease

Patient N.N., 62. Parkinson's disease

Patient A.A.N., 72. Akinetic-rigid and tremor-dominant Parkinson’s disease, stage II. Stage II grade 2 essential hypertension. Grade I heart failure. Extensive osteochondrosis

Patient W. H., 67. Akinetic-rigid tremor-dominant Parkinsons’ disease, stage II (Hoehn&Yahr)  

Patient H.R., 69. Akinetic-rigid and tremor-dominant Parkinson’s disease

Patient J. S. H.,  63.  Well-managed akinetic-rigid, tremor-dominant Parkinson’s disease

Patient W.H.,  69.  Akinetic-rigid tremor-dominant Parkinson's disease, stage II (Hoehn&Yahr). Stage II grade 3 hypertension, risk group III.

SMA

Patient A.S., 9. Type 2 SMA, grade IV S-kyphoscoliosis

Patient M.S., 1. Spinal Muscular Atrophy, type I. Tetraparesis

Other diseases and conditions

Patient N.A., 48. Fibromyalgia. Seronegative spondylarthritis. Secondary hyperalgesia. Nodular osteoarthritis. Dyshormonal neurocirculatory asthenia

Patient B.J., 61. Polymyalgia. Polyosteoarthrosis mostly affecting large joints: hip, knee, elbow and shoulder joints

Patient V.C. 51. Dyslipidemia. Diffuse-nodular goiter

Patient K., 39. Spastic paraparesis of the lower extremities

Patient F.S., 34. Organic brain damage. Affective disorder. Insomnia

Patient I.M., 17. Epilepsy. Grade I-II thoracic kyphoscoliosis

Patient N.U., 13. Sensorineural hearing loss

Patient C., 23. Traumatic brain injury

Patient M.B., 60. Chronic obstructive pulmonary disease. Lung emphysema. Diffuse pneumosclerosis

Patient G., 77. Chronic obstructive pulmonary disease.  Diffuse pneumosclerosis. Lung emphysema.  Grade III respiratory failure. Hormone dependence, steroid vasculitis.  IHD.  Atherosclerosis of aorta and coronary arteries.  Hypertension.  IIB heart failure with preserved LV systolic function. Obliterating atherosclerosis of the arteries of lower extremities.  Grade II chronic insufficiency of the arteries

Patient A.E., 40. Unstable remission of chronic systemic vasculitis with affection of mucous coats, eyes, nervous system, skin (alopecia). Azoospermia. Hypertension-induced circulatory asthenia

Patient S.N., 5. Williams-Beuren Syndrome

Patient D.C., 60. Stroke, dementia

Patient S., 56. Secondary lumbosacral radiculopathy.  Left knee osteoarthritis without functional insufficiency of the joint.  Autoimmune thyroiditis.  Persisting mild well-managed bronchial asthma without respiratory insufficiency

Patient L.M., 55. Chronic systemic lupus erythematosus


Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.

Our stories